References

* The scientific definition of a prebiotic is: nondigestible food ingredients that beneficially affect the host by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon

Source: Gibson, G.R. and Roberfroid, M.B., “Dietary Modulation of  the Human Colonic Microbiota: Introducing the Concept of  Prebiotics,” Journal of Nutrition, 125: 1401-1412 (1995).

Whether you can use the claim prebiotic on your products depends on local legislation.

 

  1. Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology 2012:22(9):1147-1162
  2. Boehm G, Jelinek J, et al. Prebiotics in infant formulas. J Clin Gastroenterol 2004;38(6 Suppl):S76-S79.
  3. Barile D, Rastall RA. Human milk and related oligosaccharides as prebiotics. Curr Opin Biotechnol 2013;24(2):214-219.
  4. Rijnierse A, Jeurink PV, et al. Food-derived oligosaccharides exhibit pharmaceutical properties. Eur J Pharmacol 2011:668 Suppl 1:S117-23.
  5. Maathuis A.J.H., Heuvel van den E.G., et al. Galacto-oligosaccharides have prebiotic activity in a dynamic in vitro colon model using a 13C-labeling technique. J. Nutr. 2012:142(7):1205-1212.
  6. Gibson GR. Dietary modulation of the human gut microflora using prebiotics. Br J Nutr 1998;80(4):S209-S212.
  7. Macfarlane GT, Steed H, et al. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol 2008;104(2):305-344.
  8. Roberfroid MB. Prebiotics and probiotics: are they functional foods? Am J Clin Nutr 2000;71(6 Suppl):1682S-1687S.
  9. Maathuis A.J.H., Heuvel van den E.G., et al. Galacto-oligosaccharides have prebiotic activity in a dynamic in vitro colon model using a 13C-labeling technique. J. Nutr. 2012:142(7):1205-1212.
  10. Ben XM, Li J, et al. Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli. World J Gastroenterol 2008;14(42):6564-6568.
  11. Fanaro S, Marten B, et al. Galacto-oligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study. J Pediatr Gastroenterol Nutr 2009;48(1):82-88.
  12. Ben XM, Zhou XY, et al. Supplementation of milk formula with galacto-oligosaccharides improves intestinal micro-flora and fermentation in term infants. Chin Med J (Engl ) 2004;117(6):927-931.
  13. Schmelze H, Wirth S, et al. Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta-palmitic acid level, and nondigestible oligosaccharides. J Pediatr Gastroenterol Nutr 2003;36(3):343-351.
  14. Costalos C, Kapiki A, et al. The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants. Early Hum Dev 2008;84(1):45-49.
  15. Scholtens PA, Alles MS, et al. Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: a randomised controlled clinical trial. J Pediatr Gastroenterol Nutr 2006;42(5):553-559.
  16. Moro GE, Mosca F, et al. Effects of a new mixture of prebiotics on faecal flora and stools in term infants. Acta Paediatr Supple 2003;91(441):77-79.
  17. Moro G, Minoli I, et al. Dosage-related bifidogenic effects of galacto- and fructooligosacchardies in formula-fed infants. J Pediatr Gastroenterol Nutr 2002;34(3):291-295.
  18. Knol J, Scholtens P, et al. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr 2005;40(1):36-42.
  19. Haarman M, Knol J. Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Appl Envrion Microbiol 2006;72(4):2359-2365.
  20. Desci T, Arato A, et al. Randomised placebo controlled double blind study on the effect of prebiotic oligosaccharides on intestinal flora in healthy infants. Orv Hetil 2005;146(48):2445-2450.
  21. Boehm G, Lidestri M, et al. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Arch Dis Child Fetal Neonatal Ed 2002;86(3):F178-F181.
  22. Wallace TC, Guarner F, et al. Human gut microbiota and its relationship to health and disease. Nutrition Reviews 2011:69(7):392-403.
  23. Björkstén B, Sepp E, et al. Allergy Development and the intestinal microflora during the first year of life. Journal of allergy and Clinical Immunology2001;108(4):516-520.
  24. Bruzzese E, Volpicelli M, et al. A formula containing galacto- and fructooligosaccharides prevents intestinal and extra-intestinal infections: an observational study. Clin Nutr 2009;28(2):156-161.
  25. Arslanoglu S, Moro GE, et al. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr 2008;138(6):1091-1095.
  26. Arslanoglu S, Moro GE, et al. Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life. J Bio Regul Homeost Agents 2012;26(3 Suppl):49-59.
  27. Moro G, Arslanoglu S, et al. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 2006;91(10):814-819.
  28. Van Hoffen E, Ruiter B, et al. A specific mixture of short-chain galactooligosaccharides and longchain fructooligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy 2009;64:484-487.
  29. Shoaf K, Mulvey GL, et al. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect Immun 2006;74(12):6920-6928.
  30. Sinclair HR, de SJ, et al. Galactooligosaccharides (GOS) inhibit Vibrio cholerae toxin binding to its GM1 receptor. J Agric Food Chem 2009;57(8):3113-3119.
  31. Macfarlane GT, Steed H, et al. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol 2008;104(2):305-344.
  32. Vos AP, M’Rabet L, et al. Immune-modulatory effects and potential working mechanisms of orally applied nondigestible carbohydrates. Crit Rev Immunol 2007;27(2):97-140.
  33. Gopalakrishnan A, Clinthorne JF, et al. Supplementation with Galacto-Oligosaccharides increases the percentage of NK cells and reduces colitis severity in Smad3-deficient mice. J Nutr 2012;142:1336-1342.
  34. Bakker-Zierikzee AM, Tol EA.Faecal SigA secretion in infants fed on pre-or probiotic infant formula. Pediatr Allergy Immunol 2006:17(2): 134-40.
  35. Quinlan PT, Lockton S, et al. The relationship between stool hardness and stool composition in breast- and formula-fed infants. J Pediatr Gastroenterol Nutr 1995;20(1):81-90.
  36. Ashley C, Johnston WH, et al. Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/ or galactooligosaccharides (GOS): double-blind, randomized, controlled trial. Nutr J 2012;11(38).
  37. Sierra C, Bernal MJ, et al. Prebiotic effect during the first year of life in healthy infants fed formula containing GOS as the only prebiotic: a multicentre, randomised, double-blind and placebo-controlled trial. Eur J Nutr 2015;54:89-99
  38. Ribeiro T, Costa-Ribeiro H, et al. Stool pattern changes in toddlers consuming a follow-on formula supplemented with polydextrose and galactooligosaccharides. J Pediatr Gastroenterol Nutr 2012;54(2):288-290.
  39. Ziegler E, Vanderhoof JA, et al. Term infants fed formula supplemented with selected blend of prebiotics grow normally and have soft stools similar to those reported for breast-fed infants. Journal of Pediatric Gastroenterology and Nutrition 2007; 44:359-364.
  40. Veereman-Wauters G, Staelens S, et al. Physiological and bifidogenic effects of prebiotic supplements in infant formulae. J Pediatr Gastroenterol Nutr 2011;52(6):763-771.
  41. Baker SS, Cochran WJ, et al. American Academy of Pediatrics. Committee on Nutrition. Calcium requirements of infants, children, and adolescents. Pediatrics 1999;104(5 Pt 1):1152-1157.
  42. Weaver CM, Martin BR, et al. Galactooligosaccharides improve mineral absorption and bone properties in growing rats through gut fermentation. J Agric Food Chem 2011;59(12):6501-6510 .
  43. Whisner CM, Martin BR, et al. Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial. Br J Nutr 2013;110(7):1292-1303.
  44. Chonan O, Watanuki M. Effect of galactooligosaccharides on calcium absorption in rats. J Nutr Sci Vitaminol (Tokyo) 1995;41(1):95-104.
  45. Chonan O, Watanuki M. The effect of 6′-galactooligosaccharides on bone mineralization of rats adapted to different levels of dietary calcium. Int J Vitam Nutr Res 1996;66(3):244-249.
  46. Scholtens PA, Alliet P, et al. Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructooligosaccharides.J Nutr 2008;138(6):1141-1147.
  47. Ladirat SE, Schoterman MHC, et al. Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment. Br J Nutr 2014; 112(4):536-46.
  48. Tamai S, Nakamura Y, et al. Effect of galactooligosaccharides intake on human fecal flora and metabolites. Oyo Toshitsu Kagaku 1994;41(3):343-348.
  49. Ito M, Kimura M, et al. Effects of transgalactosylated disaccharides on the human intestinal microflora and their metabolism. J Nutr Sci Vitaminol (Tokyo) 1993;39(3):279-288.